A team of scientists has developed a new ChatGPT-like generative artificial intelligence (AI) model that can design new drugs to treat disease.
ChatGPT gained fame in 2023 for writing emails, cracking medical and administrative examinations as well as diagnosing patients.
Inspired by ChatGPT’s popularity and wondering if this approach could speed up the drug design process, scientists in the Schmid College of Science and Technology at Chapman University in California, US decided to create their own GenAI model.
The platform, named “drugAI,” allows users to input a target protein sequence (for instance, a protein typically involved in cancer progression).
DrugAI, trained on data from the comprehensive public database BindingDB, can generate unique molecular structures from scratch, and then iteratively refine candidates, ensuring finalists exhibit strong binding affinities to respective drug targets — crucial for the efficacy of potential drugs.